Management of Migraine Headaches

Journal of Midwifery and Women's Health

Volumn 51, Issue 3, 2006, Pages 174-184

  Graves, Barbara W ^a  

^a NONE

Author keywords

acute and preventive treatment; complementary therapies; migraine headache; migraine in pregnancy

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS BUTALBITAL PLUS CAFFEINE; ANALGESIC AGENT; ANTIEMETIC AGENT; ANTIMIGRAINE AGENT; BELLADONNA LEAF; BUTORPHANOL TARTRATE; CAFERGOT; CAFFEINE; CHLORPROMAZINE; CODEINE; DEXAMETHASONE; DICLOFENAC; DICLOFENAC POTASSIUM; DIHYDROERGOTAMINE; ERGOTAMINE; FLURBIPROFEN; GRANISETRON; HYDROCORTISONE; KYTREL; LIDOCAINE; METOCLOPRAMIDE; NARATRIPTAN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PENTOBARBITAL; PLACEBO; PROCHLORPERAZINE; PROCHLORPERAZINE MALEATE; PROMETHAZINE; RIZATRIPTAN; SUMATRIPTAN; SUMATRIPTAN SUCCINATE; UNINDEXED DRUG; ZOLMITRIPTAN;

ARTICLE; BEHAVIOR THERAPY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DIARRHEA; DISEASE CLASSIFICATION; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; LIFESTYLE; LONG TERM CARE; MENSTRUAL CYCLE; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; NAUSEA; PATHOPHYSIOLOGY; PATIENT EDUCATION; PREGNANCY; PRIORITY JOURNAL; STOMACH IRRITATION; TREATMENT PLANNING;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ANALGESICS; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; BEHAVIOR THERAPY; CALCIUM CHANNEL BLOCKERS; COMPLEMENTARY THERAPIES; CONTRACEPTIVES, ORAL; DISABILITY EVALUATION; FEMALE; HUMANS; MENSTRUAL CYCLE; MIGRAINE DISORDERS; PRACTICE GUIDELINES; PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTORS; SEROTONIN AGENTS; TREATMENT OUTCOME;

EID: 33645988798     PISSN: 15269523     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmwh.2006.01.002     Document Type: Article

References (40)

1. Lipton R.B., Scher A.I., Kolodner K., et al. Migraine in the United States. Epidemiology and patterns of health care use. Neurology 58 (2002) 885-894
2. Goldberg L.D. The cost of migraine and its treatment. Am J Manag Care 11 (2005) S62-S67
3. Lipton R., and Bigal M. Migraine. Epidemiology, impact and risk factors for progression. Headache 45 Suppl 1 (2005) S1-S13
4. Lipton R.B., Amatniek J.C., Ferrari M.D., and Gross M. Migraine. Identifying and removing barriers to care. Neurology 44 Suppl 4 (1994) 63-68
5. Goadsby P.J., Lipton P.B., and Ferrari M.D. Migraine. Current understanding and treatment. N Engl J Med 346 (2002) 257-270
6. nd ed. (2002), Oxford University Press, New York
7. Schreiber C.P. Pathophysiology of migraine. Clin Fam Pract 7 (2005) 407-421
8. Goadsby P.J. Migraine. Diagnosis and management. Intern Med J 33 (2003) 436-442
9. Headache Classification Committee of the International Headache Society. Cephalalgia 24 Suppl 1 (2004) 1-160. http://www.i-h-s.org Available from: http://www.i-h-s.org [Accessed July 10, 2005]
10. Silberstein SD for the US Headache Consortium. Practice parameter: Evidenced based guidelines for migraine headache. Available from the American Academy of Neurology [online]. Available from: http://www.neurology.org/cgi/reprint/55/6/754.pdf [Accessed July 10, 2005].
11. Martin V. Simplifying the diagnosis of migraine headache. Adv Stud Med 4 (2004) 200-207
12. Silberstein S. Headache and female hormones. What you need to know. Curr Opin Neurol 14 (2001) 323-333
13. MacGregor E.A., and Hackshaw A. Prevalence of migraine on each day of the natural menstrual cycle. Neurology 63 (2004) 351-353
14. Stewart W.F., Lipton R.B., Chee E., et al. Menstrual cycle and headache in a population sample of migraineurs. Neurology 55 (2000) 1517-1523
15. Limmroth V., and Katsarava Z. Medication overuse headache. Curr Opin Neurol 17 (2004) 301-306
16. Lipton R.B., Stewart W.F., Sawyer J., and Edmeads J.G. Clinical utility of an instrument assessing migraine disability. The migraine disability assessment (MIDAS) questionnaire. Headache 41 (2001) 854-861
17. Lipton R.B., Stewart W.F., Stone A.M., Lainez M.J., and Sawyer J.P. Stratified care vs step care strategies for migraine: The disability in strategies of care study: a randomized trial. JAMA 284 (2000) 2599-2605
18. Bigal M.E., and Tepper S.J. Ergotamine and dihydroergotamine. A review. Curr Pain Headache Rep 7 (2003) 55-62
19. Aukerman G., Knutson D., and Miser W.F. Management of the acute migraine headache. Am Fam Physician 66 (2002) 2123-2130
20. Rappaport A.M., Tepper S.J., Bigal M.E., et al. The triptans formulations. How to match patients and products. CNS Drugs 17 (2003) 431-447
21. Brandes J.L. Treatment approaches to maximizing therapeutic response in migraine. Neurology 61 Suppl 4 (2003) S21-S26
22. Dodick D.W. Introduction. Cardiovascular safety and triptans in the acute treatment of migraine. Headache 44 Suppl 1 (2004) S1-S4
23. Lipton R.B., Stewart W.F., Diamond M.L., and Reed M. Prevalence and burden of migraine in the United States. Data from the American Migraine Study II. Headache 41 (2001) 646-657
24. Loder E., and Biondi D. Generals principles of migraine management. The changing role of prevention. Headache 45 Suppl 1 (2005) S33-S47
25. Silberstein S.D., and Goadsby P.J. Migraine. A preventive treatment. Cephalalgia 22 (2002) 491-512
26. Bigal M., Lipton R.B., and Krymchantowski A. The medical management of migraine. Am J Ther 11 (2004) 130-140
27. Loder E. Prophylaxis of menstrual migraine with triptans. Problems and possibilities. Neurology 59 (2002) 1677-1681
28. Campbell JK, Penzien DB, Wall EM. Evidence-based guidelines for migraine headache: Behavioral and physical treatments. Available from: aan.com/professionals/practice/guideline [Accessed July 10, 2005].
29. Boehnke C., Reuter U., Flach U., Schuh-Hofer S., Einhaupl K.M., and Arnold G. High-dose riboflavin treatment is efficacious in migraine prophylaxis. An open study in a tertiary care center. Eur J Neurol 11 (2004) 475-477
30. Diener H.C., Rahifs V.W., and Danesch U. The first placebo controlled trial of a special butterbur root extract for the prevention of migraine. Reanalysis of efficacy criteria. Eur J Neurol 51 (2004) 89-97
31. Lipton R.B., Gobel H., Einhaupl K.M., Wilks K., and Mauskop A. Petacites hybridus root (butterbur) is an effective treatment for migraine. Neurology 63 (2004) 2240-2244
32. Pittler M.H., and Ernst E. Feverfew for preventing migraine. [update of Cochrane Database Syst Rev 2000;3:CD002286; PMID: 10908545]. Cochrane Database Syst Rev 1 (2004) CD002286
33. Brummer M. Yoga and Aryurveda for headaches and migraines. Positive Health (2005) 45-48
34. Aube M. Migraine in pregnancy. Neurology 53 Suppl 1 (1999) S26-S28
35. Fox A.W., Diamond M.L., and Spierings E.L.H. Migraine during pregnancy. Options for therapy. CNS Drugs 19 (2005) 466-481
36. Loder E.W., Buse D.C., and Golub J.R. Headache and combination estrogen-progestin oral contraceptives. Integrating evidence, guidelines and clinical practice. Headache 45 (2005) 224-231
37. Hatcher R., Trussell J., and Stewart F. Contraceptive technology. 18th ed. (2004), Ardent Media, Inc, New York
38. Reproductive Health and Research, World Health Organization. Medical eligibility for contraceptive use. 3rd ed. (2004), World Health Organization, Geneva
39. Levy E., and Margolese H. Migraine headache prophylaxis and treatment with low-dose mirtazapine. Int Clin Psychopharmacol 18 (2003) 301-303
40. Lipton R.B., Bigal M., Amatniek K., and Stewart W.F. Tools for diagnosing migraine and measuring its severity. Headache 44 (2004) 387-398